Gebra Cuyún Carter

Obesity in relation to endometrial cancer risk and disease characteristics in the Women's Health Initiative

Katherine W. Reeves, Gebra Cuyún Carter, Rebecca J. Rodabough et al. · Gynecologic Oncology · 2011 · 105 citations · Full text

Obesity, Disease Characteristics, Cancer Risk +8

Heterogeneity of Response to Biologic Treatment: Perspective for Psoriasis

Emily Edson‐Heredia, K.L. Sterling, Carlos Alatorre et al. · Journal of Investigative Dermatology · 2013 · 82 citations · Full text

Biologic Treatment, Medicine, Immunology +4

Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy

Peter A. Kaufman, Masakazu Toi, Patrick Neven et al. · The Oncologist · 2019 · 72 citations · Full text

Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer

Martin Reck, Luis Paz‐Ares, Paolo Bidoli et al. · Lung Cancer · 2017 · 45 citations · Full text

Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy

M. Pérol, Tudor–Eliade Ciuleanu, Óscar Arrieta et al. · Lung Cancer · 2016 · 44 citations

Oncology, Ramucirumab-plus-docetaxel Versus Placebo-plus-docetaxel, Cancer Management +10